chr16-4777867-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_144605.5(SEPTIN12):c.1007G>A(p.Gly336Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000877 in 1,596,460 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_144605.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SEPTIN12 | NM_144605.5 | c.1007G>A | p.Gly336Glu | missense_variant | 10/10 | ENST00000268231.13 | NP_653206.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SEPTIN12 | ENST00000268231.13 | c.1007G>A | p.Gly336Glu | missense_variant | 10/10 | 1 | NM_144605.5 | ENSP00000268231.8 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152160Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000186 AC: 4AN: 214488Hom.: 0 AF XY: 0.0000258 AC XY: 3AN XY: 116172
GnomAD4 exome AF: 0.00000554 AC: 8AN: 1444300Hom.: 0 Cov.: 32 AF XY: 0.00000558 AC XY: 4AN XY: 716796
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152160Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74314
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 06, 2023 | The c.1007G>A (p.G336E) alteration is located in exon 10 (coding exon 9) of the SEPT12 gene. This alteration results from a G to A substitution at nucleotide position 1007, causing the glycine (G) at amino acid position 336 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at